A low concentration of adiponectin in the blood, typical for DM2 patients, is associated with a decrease in lipid oxidation, increased triglyceride concentrations, and compromised glucose consumption in peripheral tissues [2]. Here, ADIPOQ is linked to myotonic dystrophy type 2.